Case Study: virtual pharmaceutical stakeholders achieve a 6-month timeline reduction with Kymanox Quality by Design and custom packaging

A Kymanox Case Study

Development and Manufacturing of an Orphan Drug in Powder for Oral Solution Format​

Kymanox partnered with virtual pharmaceutical stakeholders to overcome development and manufacturing challenges for a pediatric neurological orphan drug. The customer, a virtual pharmaceutical company, faced significant hurdles in formulating a stable powder for oral solution that would ensure pediatric patient compliance and dosing accuracy. They also needed a custom packaging solution for large dose sizes and a thermolabile API, all while meeting an accelerated development timeline to serve a critically underserved patient population.

Kymanox implemented a comprehensive solution that included developing innovative custom packaging and employing Quality by Design principles. By managing the complete project lifecycle from CDMO selection to regulatory submission, Kymanox achieved a 6-month reduction in the development timeline and a 25% cost reduction. The vendor successfully delivered a high-quality, stable drug product within twelve months, exceeding client expectations and ensuring timely market access for the pediatric patients in need.


View this case study…

Kymanox

58 Case Studies